LoginRegister
    Mercks Blockbuster Drug Keytruda win EU approval for combination use in Lung CancerMerck's Blockbuster Drug Keytruda win EU approval for combination use in Lung Cancer
    Alembic Pharma okays proposal to raise up to Rs 300 cr via NCDs, informs BSEAlembic Pharma okays proposal to raise up to Rs 300 cr via NCDs, informs BSE
    U.S. appeals court invalidates Acorda patents on MS drugU.S. appeals court invalidates Acorda patents on MS drug
    JnJ faulty hip implants case: CIC directs RTI disclosure of recordsJnJ faulty hip implants case: CIC directs RTI disclosure of records
    Glenmark Pharma arm gets approval for generic asthma drug in GermanyGlenmark Pharma arm gets approval for generic asthma drug in Germany
    Max Bupa launches WeCare initiative to aid Kerala flood victimsMax Bupa launches WeCare initiative to aid Kerala flood victims
    Roche faces UK pricing row over multiple sclerosis drug OcrevusRoche faces UK pricing row over multiple sclerosis drug Ocrevus
    US redirecting 25 million dollar in aid for East Jerusalem hospitalsUS redirecting 25 million dollar in aid for East Jerusalem hospitals
    Maryland charges Insys with engaging in deceptive opioid schemeMaryland charges Insys with engaging in deceptive opioid scheme
    Opposing Online Pharmacies, 8.5 lakh chemists to call it a strike on September 28Opposing Online Pharmacies, 8.5 lakh chemists to call it a strike on September 28
    USFDA completes inspection at Caplin Point Labs sterile injectable facility in Tamil NaduUSFDA completes inspection at Caplin Point Lab's sterile injectable facility in Tamil Nadu
    Fortis arm sells 15 lakh shares in RHT to Fortis Healthcare International LtdFortis arm sells 15 lakh shares in RHT to Fortis Healthcare International Ltd
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X